Infektiöse Endokarditis

Die infektiöse Endokarditis (IE) ist eine schwere bakterielle Erkrankung – in 80 – 90% bedingt durch Streptokokken, Staphylokokken oder Enterokokken. Dabei erfolgt ca. ein Drittel der Infektionen im Krankenhaus oder im Rahmen ambulanter medizinischer Versorgung (z. B. Dialyse). Dieser Beitrag widmet sich den Risikofaktoren, den Empfehlungen zur antibiotischen Prophylaxe, den diagnostischen Herausforderungen und den aktuellen Behandlungsoptionen.

• Literatur

• 1 Murdoch DR, Corey GR, Hoen B. et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169: 463-473
• 2 Keller K, von Bardeleben RS, Ostad MA. et al. Temporal trends in the prevalence of infective endocarditis in Germany between 2005 and 2014. Am J Cardiol 2017; 119: 317-332
• 3 Benito N, Miró JM, de Lazzari E. ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators. et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 2009; 150: 586-594 Erratum in: Ann Intern Med 2010; 152: 480 Erratum in: Ann Intern Med 2010; 152: 480
• 4 Buerke FM, Horstkotte D, Levenson B. et al. Kommentar zu den 2015-Leitlinien der Europäischen Gesellschaft für Kardiologie zur Infektiösen Endokarditis. Kardiologe 2016; 10: 142-148
• 5 Habib G, Lancellotti P, Antunes MJ. ESC Scientific Document Group. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36: 3075-3128 doi:10.1093/eurheartj/ehv319
• 6 Duval X, Delahaye F, Alla F. et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 2012; 59: 1968-1976
• 7 Desimone DC, Tleyjeh IM, Correa de Sa DD. et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Associationʼs endocarditis prevention guidelines. Circulation 2012; 126: 60-64
• 8 Pasquali SK, He X, Mohamad Z. et al. Trends in endocarditis hospitalizations at US childrenʼs hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines. Am Heart J 2012; 163: 894-899
• 9 Lockhart PB, Brennan MT, Sasser HC. et al. Bacteremia associated with toothbrushing and dental extraction. Circulation 2008; 117: 3118-3125
• 10 Botelho-Nevers E, Thuny F, Casalta JP. et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009; 169: 1290-1298 doi:10.1001/archinternmed.2009.192
• 11 Thuny F, Disalvo G, Belliard O. et al. Risk of embolismand death in infective endocarditis: prognostic value of echocardiography. Circulation 2005; 112: 69-75
• 12 Erbel R, Rohmann S, Drexler M. et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur Heart J 1988; 9: 43-53
• 13 Swart LE, Scholtens AM, Tanis W. et al. 18F-fluorodeoxyglucose positron emission/computed tomography and computed tomography angiography in prosthetic heart valve endocarditis: from guidelines to clinical practice. Eur Heart J 2018; [Epub ahead of print]
• 14 Erba PA, Conti U, Lazzeri E. et al. Added value of 99 mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med 2012; 53: 1235-1243
• 15 Fagman E, Perrotta S, Bech-Hanssen O. et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol 2012; 22: 2407-2414
• 16 Vilacosta I, Graupner C, San Román JA. et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002; 39: 1489-1495
• 17 Dickerman SA, Abrutyn E, Barsic B. et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 2007; 154: 1086-1094
• 18 Kang DH, Kim YJ, Kim SH. et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 2012; 366: 2466-2673 doi:10.1056/NEJMoa1112843
• 19 Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med 1996; 335: 407-416
• 20 Wang A, Athan E, Pappas PA. et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007; 297: 1354-1361
• 21 Salaun E, Sportouch L, Barral PA. et al. Diagnosis of infective endocarditis after TAVR: Value of a multimodality imaging approach. JACC Cardiovasc Imaging 2018; 11: 143-146 doi:10.1016/j.jcmg.2017.05.016
• 22 Latib A, Naim C, De Bonis M. et al. TAVR-associated prosthetic valve infective endocarditis: results of a large, multicenter registry. J Am Coll Cardiol 2014; 64: 2176-2178 doi:10.1016/j.jacc.2014.09.021
• 23 Johansen JB, Jorgensen OD, Moller M. et al. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011; 32: 991-998
• 24 Bongiorni MG, Tascini C, Tagliaferri E. et al. Microbiology of cardiac implantable electronic device infections. Europace 2012; 14: 1334-1339
• 25 Miro JM, del Rio A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 2003; 21: 167-184
• 26 Wilson LE, Thomas DL, Astemborski J. et al. Prospective study of infective endocarditis among injection drug users. J Infect Dis 2002; 185: 1761-1766